Skip to content

twitter
linkedin
onxeo

SUBSCRIBE TO OUR NEWS

EN
FR

CONTACT

Onxeo

Onxeo designs and develops novel oncology drugs targeting tumor DNA repair functions.

COMPANY
SCIENCE
PRODUCTS
- DDR Pipeline
- AsiDNA™
- OX401
- Other
INVESTORS
NEWS & EVENTS

Half-year 2022 results

⇤

September 13, 2022
Press Release

NEWS & EVENTS

Press Releases
Events & Presentations
Shareholder Letters
Media

> SITE MAP

> LEGAL NOTICES

> FOLLOW US

COMPANY

Profile
Executive Committee
Board of Directors
Join us
Contact us

SCIENCE

DNA Damage Response
platON™
Collaborations

PRODUCTS

Pipeline
AsiDNA™
OX401
belinostat / Beleodaq®

INVESTORS

Regulated Information
Governance
Shareholder Resources
Investor Relations

NEWS AND EVENTS

NEWS & RELEASES

Press Releases
Events & Presentations
NewsLetters
Media

SUBSCRIBE TO
OUR NEWS

CONTACT
US

ONXEO SA

49, avenue du Général Martial Valin
75015 PARIS – FRANCE
+33 (0) 1 45 58 76 00

185 Alewife Brook Parkway
Suite 210, Cambridge, MA 02138
(617) 648-8674